SCYNEXIS
SCYX
#10654
Rank
โ‚ฌ22.3 M
Marketcap
2,24ย โ‚ฌ
Share price
-5.62%
Change (1 day)
338.29%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): -4,45ย โ‚ฌ

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is -4,74ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,24ย โ‚ฌ an increase over its 2024 EPS that were of -3,21ย โ‚ฌ.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,45ย โ‚ฌ259.14%
2025-1,24ย โ‚ฌ-61.36%
2024-3,21ย โ‚ฌ-131.43%
202310,21ย โ‚ฌ-195.24%
2022-10,72ย โ‚ฌ17.6%
2021-9,11ย โ‚ฌ-75.73%
2020-37,55ย โ‚ฌ-46.24%
2019-69,85ย โ‚ฌ242.14%
2018-20,42ย โ‚ฌ-70.21%
2017-68,54ย โ‚ฌ-40.51%
2016-115,20ย โ‚ฌ-41.04%
2015-195,40ย โ‚ฌ157.69%
2014-75,83ย โ‚ฌ-96.49%
2013-2.158ย โ‚ฌ307.85%
2012-529,23ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
-11,74ย โ‚ฌ 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
1,65ย โ‚ฌ-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-5,77ย โ‚ฌ 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-0,90ย โ‚ฌ-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA